We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ)

This study is currently recruiting participants.
Verified October 2016 by JSehouli, Charite University, Berlin, Germany
Sponsor:
ClinicalTrials.gov Identifier:
NCT01600573
First Posted: May 17, 2012
Last Update Posted: October 11, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
JSehouli, Charite University, Berlin, Germany
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2017
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)